• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞黏附分子:潜在的治疗与诊断意义

Cell adhesion molecules: potential therapeutic & diagnostic implications.

作者信息

Mousa Shaker A

机构信息

The Pharmaceutical Research Institute, Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY, USA.

出版信息

Mol Biotechnol. 2008 Jan;38(1):33-40. doi: 10.1007/s12033-007-0072-7. Epub 2007 Aug 15.

DOI:10.1007/s12033-007-0072-7
PMID:18095189
Abstract

The role of cell adhesion molecules (CAM) and extracellular matrix proteins (ECM) in various pathological processes including angiogenesis, thrombosis, apoptosis, cell migration & proliferation are well documented. These processes can lead to both acute and chronic disease states such as ocular diseases, metastasis, unstable angina, myocardial infarction, stroke, osteoporosis, a wide range of inflammatory diseases, vascular remodeling, and neurodegenerative disorders. A key success in this field is evident from the potential role of the platelet GPIIb/IIIa integrin in the prevention and diagnosis of various thromboembolic disorders. Additionally, the use of soluble adhesion molecules as potential diagnostic markers for acute and chronic leukocyte, platelet, and endothelial cellular insult are increasingly utilized. The development of various therapeutic and diagnostic candidates based on the key role of CAM, with special emphasis on integrins in various diseases as well as the structure-function aspects of cell adhesion and signaling of the different CAM and ECM are highlighted.

摘要

细胞黏附分子(CAM)和细胞外基质蛋白(ECM)在包括血管生成、血栓形成、细胞凋亡、细胞迁移和增殖在内的各种病理过程中的作用已有充分记载。这些过程可导致急性和慢性疾病状态,如眼部疾病、转移、不稳定型心绞痛、心肌梗死、中风、骨质疏松症、多种炎症性疾病、血管重塑和神经退行性疾病。血小板糖蛋白IIb/IIIa整合素在预防和诊断各种血栓栓塞性疾病中的潜在作用,清楚地表明了该领域的一项重大成就。此外,可溶性黏附分子作为急性和慢性白细胞、血小板及内皮细胞损伤潜在诊断标志物的应用也越来越广泛。基于细胞黏附分子的关键作用开发各种治疗和诊断候选物,特别强调整合素在各种疾病中的作用以及不同细胞黏附分子和细胞外基质蛋白的细胞黏附与信号传导的结构-功能方面。

相似文献

1
Cell adhesion molecules: potential therapeutic & diagnostic implications.细胞黏附分子:潜在的治疗与诊断意义
Mol Biotechnol. 2008 Jan;38(1):33-40. doi: 10.1007/s12033-007-0072-7. Epub 2007 Aug 15.
2
Adhesion molecules: potential therapeutic and diagnostic implications.
Methods Mol Biol. 2010;663:261-76. doi: 10.1007/978-1-60761-803-4_11.
3
Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.炎症性肠病中的黏附分子:对肠道炎症的治疗意义
Dig Liver Dis. 2005 Nov;37(11):811-8. doi: 10.1016/j.dld.2005.03.013. Epub 2005 Sep 13.
4
Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications.抗整合素作为新型药物研发靶点:潜在的治疗和诊断意义。
Curr Opin Chem Biol. 2002 Aug;6(4):534-41. doi: 10.1016/s1367-5931(02)00350-2.
5
[Adhesion molecules: their role in physiopathology and treatment of inflammatory bowel disease].[黏附分子:它们在炎症性肠病的病理生理学及治疗中的作用]
Gastroenterol Hepatol. 1999 Dec;22(10):514-24.
6
[Adhesion molecules and glomerulonephritis. Towards novel therapeutic strategies].
Med Clin (Barc). 2002 Jun 29;119(4):145-8. doi: 10.1016/s0025-7753(02)73344-7.
7
Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis.聚焦炎症的选择素、整合素和免疫球蛋白超家族细胞黏附分子的生理学和病理生理学。感染性心内膜炎的范例模型。
Cell Commun Adhes. 2011 Jun;18(3):19-32. doi: 10.3109/15419061.2011.606381. Epub 2011 Sep 5.
8
Integrin alpha4beta1/VCAM-1 pathway mediates primary adhesion of RAW117 lymphoma cells to hepatic sinusoidal endothelial cells under flow.整合素α4β1/血管细胞黏附分子-1通路介导RAW117淋巴瘤细胞在流动状态下与肝窦内皮细胞的初始黏附。
Clin Exp Metastasis. 1999;17(8):669-76. doi: 10.1023/a:1006747106885.
9
Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.扩张型心肌病中细胞黏附分子的表达:炎症性心肌病中内皮激活的证据。
Circulation. 1999 Apr 27;99(16):2124-31. doi: 10.1161/01.cir.99.16.2124.
10
Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration.细胞黏附分子、白细胞迁移以及减少白细胞浸润的策略。
J Vet Intern Med. 2001 Nov-Dec;15(6):516-29. doi: 10.1892/0891-6640(2001)015<0516:camlta>2.3.co;2.

引用本文的文献

1
Profile of soluble cell adhesion molecules as potential biomarkers in the cardiac stages of chronic Chagas disease.可溶性细胞粘附分子作为慢性恰加斯病心脏阶段潜在生物标志物的概况
Front Immunol. 2025 Mar 7;16:1541860. doi: 10.3389/fimmu.2025.1541860. eCollection 2025.
2
Enhanced interaction between genome-edited mesenchymal stem cells and platelets improves wound healing in mice.基因编辑的间充质干细胞与血小板之间增强的相互作用可改善小鼠的伤口愈合。
J Tissue Eng. 2024 Sep 23;15:20417314241268917. doi: 10.1177/20417314241268917. eCollection 2024 Jan-Dec.
3
Perilla oil and α-linolenic acid ameliorated thrombosis in rats induced by collagen and epinephrine.

本文引用的文献

1
Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.血小板糖蛋白IIb/IIIa拮抗剂XV459在肝素诱导的血小板减少症中的应用
Am J Hematol. 2007 Apr;82(4):276-82. doi: 10.1002/ajh.20801.
2
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes.一种非肽类整合素拮抗剂可通过阻断整合素α5β1-纤连蛋白-M1蛋白复合物的形成来抑制上皮细胞对化脓性链球菌的摄取。
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2858-63. doi: 10.1073/pnas.050587897.
3
Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
紫苏油和α-亚麻酸改善了胶原蛋白和肾上腺素诱导的大鼠血栓形成。
Food Sci Biotechnol. 2023 Jan 25;32(7):997-1003. doi: 10.1007/s10068-022-01241-6. eCollection 2023 Jun.
4
Levels of adhesion molecules and clinical outcomes in patients with ischemic stroke after mechanical thrombectomy.机械取栓术后缺血性脑卒中患者的黏附分子水平与临床结局
Front Neurol. 2022 Sep 29;13:1024162. doi: 10.3389/fneur.2022.1024162. eCollection 2022.
5
The progress of research on histone methylation in ischemic stroke pathogenesis.组蛋白甲基化在缺血性脑卒中发病机制中的研究进展
J Physiol Biochem. 2022 Feb;78(1):1-8. doi: 10.1007/s13105-021-00841-w. Epub 2021 Sep 2.
6
The Impact of Spaceflight and Simulated Microgravity on Cell Adhesion.航天飞行和模拟微重力对细胞黏附的影响。
Int J Mol Sci. 2020 Apr 25;21(9):3031. doi: 10.3390/ijms21093031.
7
Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities.乳腺癌肿瘤基质:细胞成分、表型异质性、细胞间通讯、预后意义及治疗机会
Cancers (Basel). 2019 May 13;11(5):664. doi: 10.3390/cancers11050664.
8
Associations of intercellular adhesion molecule-1 rs5498 polymorphism with ischemic stroke: A meta-analysis.细胞间黏附分子-1 rs5498 多态性与缺血性脑卒中的关联:Meta 分析。
Mol Genet Genomic Med. 2019 Jun;7(6):e643. doi: 10.1002/mgg3.643. Epub 2019 Apr 17.
9
Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma.整合素作为人类恶性黑色素瘤器官特异性转移的治疗靶点。
J Exp Clin Cancer Res. 2018 Apr 27;37(1):92. doi: 10.1186/s13046-018-0763-x.
10
Microfluidic Print-to-Synthesis Platform for Efficient Preparation and Screening of Combinatorial Peptide Microarrays.微流控打印-合成平台用于高效制备和筛选组合肽微阵列。
Anal Chem. 2018 May 1;90(9):5833-5840. doi: 10.1021/acs.analchem.8b00371. Epub 2018 Apr 13.
新型锝-99m标记的血小板糖蛋白IIb/IIIa受体拮抗剂作为静脉和动脉血栓形成的潜在显像剂。
Coron Artery Dis. 1998;9(2-3):131-41.
4
Long-term administration of glycoprotein IIb/IIIa antagonists.
Am Heart J. 1998 May;135(5 Pt 2 Su):S113-8. doi: 10.1016/s0002-8703(98)70239-x.
5
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction.急性冠状动脉综合征患者口服血小板糖蛋白IIb/IIIa拮抗剂西拉非班的随机试验:心肌梗死溶栓治疗(TIMI)12试验结果
Circulation. 1998 Feb 3;97(4):340-9. doi: 10.1161/01.cir.97.4.340.
6
Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety.
Circulation. 1998 Feb 3;97(4):312-4. doi: 10.1161/01.cir.97.4.312.
7
Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men.非肽类血小板糖蛋白IIb/IIIa拮抗剂弗拉达非班及其口服活性前药莱弗拉达非班对男性血小板聚集具有深度且持续的抑制作用。
Circulation. 1997 Aug 19;96(4):1130-8. doi: 10.1161/01.cir.96.4.1130.
8
Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo.血小板内皮细胞黏附分子(PECAM)在体内和体外对受损但未剥脱的内皮上血小板黏附/聚集的作用。
Stroke. 1996 Apr;27(4):709-11. doi: 10.1161/01.str.27.4.709.
9
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.MK-383(L-700,462)是一种选择性非肽类血小板糖蛋白IIb/IIIa拮抗剂,在人体中具有活性。
Circulation. 1993 Oct;88(4 Pt 1):1512-7. doi: 10.1161/01.cir.88.4.1512.
10
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study.溶栓治疗后用单克隆抗体7E3 Fab深度抑制血小板聚集。心肌梗死溶栓与血管成形术(TAMI)8项初步研究的结果。
J Am Coll Cardiol. 1993 Aug;22(2):381-9. doi: 10.1016/0735-1097(93)90041-x.